These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31369234)

  • 1. Cellular Targeting of Bispecific Antibody-Functionalized Poly(ethylene glycol) Capsules: Do Shape and Size Matter?
    Song D; Cui J; Ju Y; Faria M; Sun H; Howard CB; Thurecht KJ; Caruso F
    ACS Appl Mater Interfaces; 2019 Aug; 11(32):28720-28731. PubMed ID: 31369234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies.
    Cui J; Ju Y; Houston ZH; Glass JJ; Fletcher NL; Alcantara S; Dai Q; Howard CB; Mahler SM; Wheatley AK; De Rose R; Brannon PT; Paterson BM; Donnelly PS; Thurecht KJ; Caruso F; Kent SJ
    Adv Healthc Mater; 2019 May; 8(9):e1801607. PubMed ID: 30868751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.
    Howard CB; Fletcher N; Houston ZH; Fuchs AV; Boase NR; Simpson JD; Raftery LJ; Ruder T; Jones ML; de Bakker CJ; Mahler SM; Thurecht KJ
    Adv Healthc Mater; 2016 Aug; 5(16):2055-68. PubMed ID: 27283923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent.
    Asano R; Sone Y; Makabe K; Tsumoto K; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    Clin Cancer Res; 2006 Jul; 12(13):4036-42. PubMed ID: 16818703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2.
    Parker CL; McSweeney MD; Lucas AT; Jacobs TM; Wadsworth D; Zamboni WC; Lai SK
    Nanomedicine; 2019 Oct; 21():102076. PubMed ID: 31394261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31038480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific Antibodies for Targeted Delivery of Dendritic Polyglycerol (dPG) Prodrug Conjugates.
    Mehrabadi FS; Adelmann J; Gupta S; Wedepohl S; Calderón M; Brinkmann U; Haag R
    Curr Cancer Drug Targets; 2016; 16(7):639-49. PubMed ID: 26853135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake.
    Cui J; Alt K; Ju Y; Gunawan ST; Braunger JA; Wang TY; Dai Y; Dai Q; Richardson JJ; Guo J; Björnmalm M; Hagemeyer CE; Caruso F
    Biomacromolecules; 2019 Sep; 20(9):3592-3600. PubMed ID: 31448896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics.
    Zeng F; Lee H; Allen C
    Bioconjug Chem; 2006; 17(2):399-409. PubMed ID: 16536472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verteporfin-Loaded Poly(ethylene glycol)-Poly(beta-amino ester)-Poly(ethylene glycol) Triblock Micelles for Cancer Therapy.
    Kim J; Shamul JG; Shah SR; Shin A; Lee BJ; Quinones-Hinojosa A; Green JJ
    Biomacromolecules; 2018 Aug; 19(8):3361-3370. PubMed ID: 29940101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes.
    Vukovic N; Halabi S; Russo-Cabrera JS; Blokhuis B; Berraondo P; Redegeld FAM; Zaiss DMW
    J Biol Chem; 2022 Aug; 298(8):102153. PubMed ID: 35718062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly and degradation of low-fouling click-functionalized poly(ethylene glycol)-based multilayer films and capsules.
    Leung MK; Such GK; Johnston AP; Biswas DP; Zhu Z; Yan Y; Lutz JF; Caruso F
    Small; 2011 Apr; 7(8):1075-85. PubMed ID: 21425467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles.
    Kao CH; Wang JY; Chuang KH; Chuang CH; Cheng TC; Hsieh YC; Tseng YL; Chen BM; Roffler SR; Cheng TL
    Biomaterials; 2014 Dec; 35(37):9930-9940. PubMed ID: 25212525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer.
    Cheng YA; Wu TH; Wang YM; Cheng TL; Chen IJ; Lu YC; Chuang KH; Wang CK; Chen CY; Lin RA; Chen HJ; Liao TY; Liu ES; Chen FM
    J Nanobiotechnology; 2020 Aug; 18(1):118. PubMed ID: 32854720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer.
    Schanzer JM; Wartha K; Moessner E; Hosse RJ; Moser S; Croasdale R; Trochanowska H; Shao C; Wang P; Shi L; Weinzierl T; Rieder N; Bacac M; Ries CH; Kettenberger H; Schlothauer T; Friess T; Umana P; Klein C
    MAbs; 2016; 8(4):811-27. PubMed ID: 26984378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between a macrophage cell line (J774A1) and surface-modified poly (D,L-lactide) nanocapsules bearing poly(ethylene glycol).
    Mosqueira VC; Legrand P; Gref R; Heurtault B; Appel M; Barratt G
    J Drug Target; 1999; 7(1):65-78. PubMed ID: 10614816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.